151 related articles for article (PubMed ID: 28057744)
21. Clonally rearranged antigen receptor gene DNA studies in evaluation of susceptibility of neoplastic lymphocytic and plasmacytic disorders to selective loss in long-term marrow culture.
Farag SS; Firkin FC
Leukemia; 1994 Aug; 8(8):1369-74. PubMed ID: 8057675
[TBL] [Abstract][Full Text] [Related]
22. CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.
Mestrallet F; Sujobert P; Sarkozy C; Traverse-Glehen A; Callet-Bauchu E; Magaud JP; Salles G; Baseggio L
Cytometry B Clin Cytom; 2016 Sep; 90(5):433-9. PubMed ID: 26482097
[TBL] [Abstract][Full Text] [Related]
23. Identification of genes whose expression patterns differ in benign lymphoid tissue and follicular, mantle cell, and small lymphocytic lymphoma.
Schmechel SC; LeVasseur RJ; Yang KH; Koehler KM; Kussick SJ; Sabath DE
Leukemia; 2004 Apr; 18(4):841-55. PubMed ID: 14961037
[TBL] [Abstract][Full Text] [Related]
24. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal B cell lymphocytosis and "in situ" lymphoma.
Karube K; Scarfò L; Campo E; Ghia P
Semin Cancer Biol; 2014 Feb; 24():3-14. PubMed ID: 23999128
[TBL] [Abstract][Full Text] [Related]
26. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
27. Histologically transformed follicular lymphoma exhibits protein profiles different from both non-transformed follicular and de novo diffuse large B-cell lymphoma.
Ludvigsen M; Madsen C; Kamper P; Hamilton-Dutoit SJ; Bendix K; d'Amore F; Honoré B
Blood Cancer J; 2015 Mar; 5(3):e293. PubMed ID: 25768407
[No Abstract] [Full Text] [Related]
28. [Application of interphase fluorescence in situ hybridization in the diagnosis of lymphoma].
Bi R; Lin DM; Han YL; Lu J; Xue LY; Zheng S; Wang MR; Lü N
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):733-8. PubMed ID: 20079011
[TBL] [Abstract][Full Text] [Related]
29. Richter syndrome with follicular colonization of chronic lymphocytic leukemia/small lymphocytic lymphoma cells mimicking follicular lymphoma.
Tabata R; Tabata C; Nagai T; Yasumizu R; Kojima M
Int J Surg Pathol; 2014 Dec; 22(8):736-43. PubMed ID: 24249845
[TBL] [Abstract][Full Text] [Related]
30. Mantle cell lymphoma-variant Richter syndrome: Detailed molecular-cytogenetic and backtracking analysis reveals slow evolution of a pre-MCL clone in parallel with CLL over several years.
Klener P; Fronkova E; Berkova A; Jaksa R; Lhotska H; Forsterova K; Soukup J; Kulvait V; Vargova J; Fiser K; Prukova D; Alam M; Calvin Lenyeletse Maswabi B; Michalova K; Zemanova Z; Jancuskova T; Pekova S; Trneny M
Int J Cancer; 2016 Nov; 139(10):2252-60. PubMed ID: 27407063
[TBL] [Abstract][Full Text] [Related]
31. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
[TBL] [Abstract][Full Text] [Related]
32. Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping.
Costa ES; Pedreira CE; Barrena S; Lecrevisse Q; Flores J; Quijano S; Almeida J; del Carmen García-Macias M; Bottcher S; Van Dongen JJ; Orfao A
Leukemia; 2010 Nov; 24(11):1927-33. PubMed ID: 20844562
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric MRD detection in selected mature B-cell malignancies.
Böttcher S; Ritgen M; Kneba M
Methods Mol Biol; 2013; 971():149-74. PubMed ID: 23296963
[TBL] [Abstract][Full Text] [Related]
34. Role of blood and bone marrow examination in the diagnosis of mature lymphoid neoplasms in patients presenting with isolated splenomegaly.
Sreedharanunni S; Sachdeva MU; Malhotra P; Ahluwalia J; Naseem S; Prakash G; Khadwal A; Sharma P; Kumar N; Varma N; Varma S; Das R
Hematology; 2015 Oct; 20(9):530-7. PubMed ID: 25760312
[TBL] [Abstract][Full Text] [Related]
35. Mature B-cell leukemias with more than 55% prolymphocytes. A heterogeneous group that includes an unusual variant of mantle cell lymphoma.
Schlette E; Bueso-Ramos C; Giles F; Glassman A; Hayes K; Medeiros LJ
Am J Clin Pathol; 2001 Apr; 115(4):571-81. PubMed ID: 11293906
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of immune checkpoints in Richter syndrome identifies LAG3 as a potential therapeutic target.
Gould C; Lickiss J; Kankanige Y; Yerneni S; Lade S; Gandhi MK; Chin C; Yannakou CK; Villa D; Slack GW; Markham JF; Tam CS; Nelson N; Seymour JF; Dickinson M; Neeson PJ; Westerman D; Blombery P
Br J Haematol; 2021 Oct; 195(1):113-118. PubMed ID: 34426978
[TBL] [Abstract][Full Text] [Related]
37. [Lymphoplasmacytic lymphoma with Waldenström's macroglobulinemia: a clinicopathological and immunophenotypic study of 40 Chinese patients].
Liang DN; Li GD; Dai L; Huang J; Wang WY; Feng WH; Li FY; Liao DY
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):728-32. PubMed ID: 20079010
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
[TBL] [Abstract][Full Text] [Related]
39. Integrative gene expression profiling reveals G6PD-mediated resistance to RNA-directed nucleoside analogues in B-cell neoplasms.
McBrayer SK; Yarrington M; Qian J; Feng G; Shanmugam M; Gandhi V; Krett NL; Rosen ST
PLoS One; 2012; 7(7):e41455. PubMed ID: 22848499
[TBL] [Abstract][Full Text] [Related]
40. The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.
Hudecek M; Schmitt TM; Baskar S; Lupo-Stanghellini MT; Nishida T; Yamamoto TN; Bleakley M; Turtle CJ; Chang WC; Greisman HA; Wood B; Maloney DG; Jensen MC; Rader C; Riddell SR
Blood; 2010 Nov; 116(22):4532-41. PubMed ID: 20702778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
